本页面由Tiger Trade Technology Pte. Ltd.提供服务

碧迪医疗

188.89
+5.142.80%
盘后:188.890.00000.00%19:45 EDT
成交量:118.44万
成交额:2.23亿
市值:514.51亿
市盈率:56.71
高:188.92
开:184.32
低:184.32
收:183.75
52周最高:213.08
52周最低:140.11
股本:2.72亿
流通股本:2.72亿
量比:0.68
换手率:0.44%
股息:4.19
股息率:2.22%
每股收益(TTM):3.33
每股收益(LYR):5.83
净资产收益率:6.61%
总资产收益率:4.34%
市净率:2.11
市盈率(LYR):32.38

数据加载中...

2024/06/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/05

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/05

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/27

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities